A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs.
Saved in:
| Title: | A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs. |
|---|---|
| Authors: | Conway AJ; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Rosanwo TO; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Williamson TE; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA., Landry S; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA., Kinney MA; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Clark MA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA., Vo LT; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Rowe RG; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Marion W; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Zhang Y; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Mullin NK; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Shi M; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Archer NM; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Heeney MM; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Schlaeger TM; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Bauer DE; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Duraisingh MT; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA., Brugnara C; Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA., North TE; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA. Electronic address: Trista.North@childrens.harvard.edu., Daley GQ; Stem Cell Program, Boston Children's Hospital, Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA. Electronic address: George_Daley@childrens.harvard.edu. |
| Source: | Experimental hematology [Exp Hematol] 2025 Dec; Vol. 152, pp. 105264. Date of Electronic Publication: 2025 Sep 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
